Skip to main content

Towards medicines for all​

UPCOMING WEBINAR

JOIN THE EFFORT

PROBE STORY

  • Who we are
    • About
    • Contributors
    • Target 2035 Phases
  • What we do
    • Open science movement
    • Cache
    • FAQ
    • Chemical Probes
  • Webinars
    • Upcoming Webinar
    • Archived recordings
    • Webinar hosts & speakers
  • Get involved
    • Join the effort
    • Sign-up
    • Resources
    • Contact
    • Target 2035 at ICBS2022

Who ?

Scientists and researchers studying human health, disease and drug discovery.

What ?

An open science, global movement focusing on the creation of chemical and biological tools to study human proteins and inform drug discovery.​

Why ?

Freely available probes to human proteins will enable discovery of new medicines.

Highlights

How to access crystallographic fragment screens at Diamond Light Source

Chemical Probe Story

Inhibition of type I PRMTs

Chemical probe MS023: Inspiration for the development of clinical candidates

Webinars

Feb 21 2023
How to access crystallographic fragment screens at Diamond Light Source
Sep 20 2022
Targeting Deubiquitinases for Therapeutic Benefit
Jun 14 2022
Towards autonomous bioactive molecular discovery
May 24 2022
The Power of High-Content Imaging to probe Ligand Binding
Apr 05 2022
Drugging the Undruggable: Targeted Protein Degradation as Medicine
 
Logo
target2035@thesgc.org
v3.24.1.9
About
Contact
Phases
Login
Read more
Upcoming webinar
Archived Recordings
Links
Privacy policy

Target 2035

All rights reserved

EUbOPEN

The Tareget 2035 initative is supported by EUbOPEN. The EUbOPEN project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 875510. This Joint Undertaking receives support from the European Union's Horizon 2020 research and innovation programme, EFPIA companies and Associated Partners: KTH, OICR, Diamond and McGill. This communication reflects the views of the authors and neither IMI nor the European Union, EFPIA or any Associated Partners are liable for any use that may be made of the information contained herein.

efpia_imi_eu

Target 2035 website is licensed under CC-BY